Matches in SemOpenAlex for { <https://semopenalex.org/work/W1937458778> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W1937458778 endingPage "7" @default.
- W1937458778 startingPage "101" @default.
- W1937458778 abstract "We have examined the ability of bryostatin 1 to inhibit the in vitro growth and in vivo development of a panel of four murine tumors of diverse tissue origins. A wide range of antiproliferative responses was observed for the four tumors. At 100 ng/ml the in vitro growth of the Renca renal adenocarcinoma, the B16 melanoma, the M5076 reticulum cell sarcoma, and the L10A B-cell lymphoma were inhibited by 0, 40, 40, and 94% respectively. All three cell lines sensitive to bryostatin in vitro responded to multiple dose, 1 microgram/injection/day in vivo i.p., bryostatin therapy. Only the in vitro resistant Renca tumor failed to respond to bryostatin in vivo. The correlation between in vitro and in vivo antitumor efficacy suggests a direct mechanism of antitumor activity for bryostatin. Both local regional therapy (M5076 i.p.) and systemic therapy (B16 lung metastases and L10A s.c. tumors) with bryostatin were successful at prolonging survival time. Multiple i.p. doses of bryostatin at a minimum level of 0.5-1.0 microgram/injection were required to observe significant in vivo antitumor effects. The success of in vivo administration of bryostatin in mice bearing 8-10-mm s.c. masses of L10A lymphoma (5-10 x 10(9)) and our further observation that five of a panel of six human B-cell lymphoma cell lines were sensitive to the growth inhibitory effects of bryostatin in vitro suggest that bryostatin may be effective in treating lymphoid malignancies in humans." @default.
- W1937458778 created "2016-06-24" @default.
- W1937458778 creator A5004718691 @default.
- W1937458778 creator A5036240496 @default.
- W1937458778 creator A5039707350 @default.
- W1937458778 creator A5047097488 @default.
- W1937458778 date "1992-01-01" @default.
- W1937458778 modified "2023-09-28" @default.
- W1937458778 title "Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity." @default.
- W1937458778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1727368" @default.
- W1937458778 hasPublicationYear "1992" @default.
- W1937458778 type Work @default.
- W1937458778 sameAs 1937458778 @default.
- W1937458778 citedByCount "63" @default.
- W1937458778 countsByYear W19374587782012 @default.
- W1937458778 countsByYear W19374587782014 @default.
- W1937458778 countsByYear W19374587782019 @default.
- W1937458778 countsByYear W19374587782021 @default.
- W1937458778 countsByYear W19374587782022 @default.
- W1937458778 crossrefType "journal-article" @default.
- W1937458778 hasAuthorship W1937458778A5004718691 @default.
- W1937458778 hasAuthorship W1937458778A5036240496 @default.
- W1937458778 hasAuthorship W1937458778A5039707350 @default.
- W1937458778 hasAuthorship W1937458778A5047097488 @default.
- W1937458778 hasConcept C126322002 @default.
- W1937458778 hasConcept C150903083 @default.
- W1937458778 hasConcept C170493617 @default.
- W1937458778 hasConcept C202751555 @default.
- W1937458778 hasConcept C203014093 @default.
- W1937458778 hasConcept C207001950 @default.
- W1937458778 hasConcept C2779338263 @default.
- W1937458778 hasConcept C2910806222 @default.
- W1937458778 hasConcept C502942594 @default.
- W1937458778 hasConcept C54355233 @default.
- W1937458778 hasConcept C55493867 @default.
- W1937458778 hasConcept C71924100 @default.
- W1937458778 hasConcept C81885089 @default.
- W1937458778 hasConcept C86803240 @default.
- W1937458778 hasConcept C88045685 @default.
- W1937458778 hasConcept C98274493 @default.
- W1937458778 hasConceptScore W1937458778C126322002 @default.
- W1937458778 hasConceptScore W1937458778C150903083 @default.
- W1937458778 hasConceptScore W1937458778C170493617 @default.
- W1937458778 hasConceptScore W1937458778C202751555 @default.
- W1937458778 hasConceptScore W1937458778C203014093 @default.
- W1937458778 hasConceptScore W1937458778C207001950 @default.
- W1937458778 hasConceptScore W1937458778C2779338263 @default.
- W1937458778 hasConceptScore W1937458778C2910806222 @default.
- W1937458778 hasConceptScore W1937458778C502942594 @default.
- W1937458778 hasConceptScore W1937458778C54355233 @default.
- W1937458778 hasConceptScore W1937458778C55493867 @default.
- W1937458778 hasConceptScore W1937458778C71924100 @default.
- W1937458778 hasConceptScore W1937458778C81885089 @default.
- W1937458778 hasConceptScore W1937458778C86803240 @default.
- W1937458778 hasConceptScore W1937458778C88045685 @default.
- W1937458778 hasConceptScore W1937458778C98274493 @default.
- W1937458778 hasIssue "1" @default.
- W1937458778 hasLocation W19374587781 @default.
- W1937458778 hasOpenAccess W1937458778 @default.
- W1937458778 hasPrimaryLocation W19374587781 @default.
- W1937458778 hasRelatedWork W1983855168 @default.
- W1937458778 hasRelatedWork W2020692772 @default.
- W1937458778 hasRelatedWork W2046443170 @default.
- W1937458778 hasRelatedWork W2047613953 @default.
- W1937458778 hasRelatedWork W2104838039 @default.
- W1937458778 hasRelatedWork W2173904357 @default.
- W1937458778 hasRelatedWork W2367179163 @default.
- W1937458778 hasRelatedWork W2416964709 @default.
- W1937458778 hasRelatedWork W2464301138 @default.
- W1937458778 hasRelatedWork W2183432931 @default.
- W1937458778 hasVolume "52" @default.
- W1937458778 isParatext "false" @default.
- W1937458778 isRetracted "false" @default.
- W1937458778 magId "1937458778" @default.
- W1937458778 workType "article" @default.